Prosecution Insights
Last updated: October 04, 2026

Neuboron Therapy System Ltd.

Technology areas: Semiconductors, Circuits & Optics • Transportation, E-Commerce & Mechanical Systems

6 pending office actions • 3 art units • 5 examiners • 0 of 6 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days

Analysis

Neuboron Therapy System Ltd. operates within the Semiconductors, Circuits & Optics technology area, with a portfolio currently containing 5 pending office actions. These actions are distributed among 4 distinct examiners, indicating that most matters are being reviewed by different individuals. The portfolio is active in 2 distinct art units, which suggests that the technical subject matter remains concentrated within a few specific areas of semiconductor or optical technology.

The busiest examiner for this portfolio is OSENBAUGH-STEWART, ELIZA W, who is responsible for 2 busiest examiner pending office actions. Since there are 5 pending office actions in total, this examiner handles a significant portion of the current workload. The involvement of 2 distinct art units means that the prosecution strategy only needs to account for the standards of two different technical departments at the USPTO. For practitioners, the fact that 4 distinct examiners are involved requires coordination, but the concentration of 2 busiest examiner pending office actions under the busiest examiner provides a focal point for the portfolio's active matters. This balance of 4 distinct examiners and 2 distinct art units allows for a manageable prosecution landscape.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

6
Total Pending OAs
4
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (33%)
4
Medium (67%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (17%)
§103 only4 (67%)
Multi-statute (no §101)1 (17%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
3
Semiconductors
50% of docket
1
Mechanical / Eng
17% of docket
2
Business / Other
33% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
OSENBAUGH-STEWART, ELIZA W 2 73.0% +16.7%
BORISSOV, IGOR N 1 28.5% +41.8%
CRADDOCK, ROBERT J 1 84.0% +14.4%
CASLER, BRIAN L 1 78.8% +22.2%
CHANG, HANWAY 1 86.1% +7.7%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18099316 RADIOTHERAPY SYSTEM AND METHOD FOR CONTROLLING SAFETY INTERLOCK THEREOF CHANG, HANWAY —

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
19369728 CONTROL METHOD AND APPARATUS FOR DOSE CALCULATION SYSTEM, AND DOSE CALCULATION SYSTEM BORISSOV, IGOR N —
18941359 TREATMENT PLANNING SYSTEM, AUTOMATIC OVERLAP CHECKING METHOD, AND METHOD FOR FORMULATING TREATMENT PLAN CRADDOCK, ROBERT J —

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
19369728 CONTROL METHOD AND APPARATUS FOR DOSE CALCULATION SYSTEM, AND DOSE CALCULATION SYSTEM BORISSOV, IGOR N —
18941359 TREATMENT PLANNING SYSTEM, AUTOMATIC OVERLAP CHECKING METHOD, AND METHOD FOR FORMULATING TREATMENT PLAN CRADDOCK, ROBERT J —
18756566 CALIBRATION METHOD, CALIBRATION DEVICE AND CALIBRATION SYSTEM OF LASER POSITIONING SYSTEM CASLER, BRIAN L —
18090575 NEUTRON CAPTURE THERAPY APPARATUS AND OPERATION METHOD OF MONITORING SYSTEM THEREOF OSENBAUGH-STEWART, ELIZA W —
18080817 NEUTRON CAPTURE THERAPY DEVICE AND OPERATION METHOD OF MONITORING SYSTEM THEREOF OSENBAUGH-STEWART, ELIZA W —

Top Art Units

Art UnitApps
2881 2
3685 1
2878 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19369728 CONTROL METHOD AND APPARATUS FOR DOSE CALCULATION SYSTEM, AND DOSE CALCULATION SYSTEM BORISSOV, IGOR N 3685 §101§102 Non-Final OA — Pending Oct 27, 2025
18941359 TREATMENT PLANNING SYSTEM, AUTOMATIC OVERLAP CHECKING METHOD, AND METHOD FOR FORMULATING TREATMENT PLAN CRADDOCK, ROBERT J — §102§103 Non-Final OA — Pending Nov 08, 2024
18756566 CALIBRATION METHOD, CALIBRATION DEVICE AND CALIBRATION SYSTEM OF LASER POSITIONING SYSTEM CASLER, BRIAN L — §103 Non-Final OA — Pending Jun 27, 2024
18099316 RADIOTHERAPY SYSTEM AND METHOD FOR CONTROLLING SAFETY INTERLOCK THEREOF CHANG, HANWAY 2878 §103 Final Rejection — Pending Jan 20, 2023
18090575 NEUTRON CAPTURE THERAPY APPARATUS AND OPERATION METHOD OF MONITORING SYSTEM THEREOF OSENBAUGH-STEWART, ELIZA W 2881 §103 Non-Final OA — Pending Dec 29, 2022
18080817 NEUTRON CAPTURE THERAPY DEVICE AND OPERATION METHOD OF MONITORING SYSTEM THEREOF OSENBAUGH-STEWART, ELIZA W 2881 §103 Final Rejection — Pending Dec 14, 2022

Managing Neuboron Therapy System Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month